These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
668 related items for PubMed ID: 18703565
1. Successful treatment of vitamin D unresponsive hypoparathyroidism with multipulse subcutaneous infusion of teriparatide. Puig-Domingo M, Díaz G, Nicolau J, Fernández C, Rueda S, Halperin I. Eur J Endocrinol; 2008 Nov; 159(5):653-7. PubMed ID: 18703565 [Abstract] [Full Text] [Related]
2. Efficacy and safety of long term treatment of unresponsive hypoparathyroidism using multipulse subcutaneous infusion of teriparatide. Díaz-Soto G, Mora-Porta M, Nicolau J, Perea V, Halperin I, Puig-Domingo M. Horm Metab Res; 2012 Sep; 44(9):708-10. PubMed ID: 22473758 [Abstract] [Full Text] [Related]
3. Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study. Clarke BL, Kay Berg J, Fox J, Cyran JA, Lagast H. Clin Ther; 2014 May; 36(5):722-36. PubMed ID: 24802860 [Abstract] [Full Text] [Related]
6. [Reduction in requirements of oral calcium and 1-25 dihydroxy vitamin D in patients with post-surgical hypoparathyroidism treated with teriparatide (PTH1-34)]. Gutiérrez-Cerecedo LE, Vergara-López A, Rosas-Barrientos JV, Guillén-González MÁ. Gac Med Mex; 2016 May; 152(3):322-8. PubMed ID: 27335186 [Abstract] [Full Text] [Related]
8. Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study. Mannstadt M, Clarke BL, Vokes T, Brandi ML, Ranganath L, Fraser WD, Lakatos P, Bajnok L, Garceau R, Mosekilde L, Lagast H, Shoback D, Bilezikian JP. Lancet Diabetes Endocrinol; 2013 Dec; 1(4):275-83. PubMed ID: 24622413 [Abstract] [Full Text] [Related]
9. Sporadic hypoparathyroidism treated with teriparatide: a case report and literature review. Angelopoulos NG, Goula A, Tolis G. Exp Clin Endocrinol Diabetes; 2007 Jan; 115(1):50-4. PubMed ID: 17286236 [Abstract] [Full Text] [Related]
12. Teriparatide (rhPTH 1-34) treatment in the pediatric age: long-term efficacy and safety data in a cohort with genetic hypoparathyroidism. Tuli G, Buganza R, Tessaris D, Einaudi S, Matarazzo P, de Sanctis L. Endocrine; 2020 Feb; 67(2):457-465. PubMed ID: 31705387 [Abstract] [Full Text] [Related]
13. Treatment of unresponsive hypoparathyroidism when the oral route administration is not possible: considering subcutaneous teriparatide. Añón AO, Porta MM, López CQ, Hanzu FA, Rabinovich IH. Endocrinol Nutr; 2015 Feb; 62(7):361-2. PubMed ID: 25959089 [No Abstract] [Full Text] [Related]
14. Continuous Teriparatide Treatment in Chronic Hypoparathyroidism: A Case Report. Saraiva M, Chaves AC, Assunção G, Saraiva J, Carvalho R. Am J Case Rep; 2021 Aug 14; 22():e931739. PubMed ID: 34389697 [Abstract] [Full Text] [Related]
15. Recombinant Human Parathyroid Hormone (1-84): A Review in Hypoparathyroidism. Kim ES, Keating GM. Drugs; 2015 Jul 14; 75(11):1293-303. PubMed ID: 26177893 [Abstract] [Full Text] [Related]